222. 一次性ネフローゼ症候群 Primary nephrotic syndrome Clinical trials / Disease details


臨床試験数 : 285 薬物数 : 285 - (DrugBank : 108) / 標的遺伝子数 : 62 - 標的パスウェイ数 : 191

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02921789
(ClinicalTrials.gov)
May 22, 201730/9/2016Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant RecipientsA Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant RecipientsKidney Transplantation;Focal Segmental Glomerulosclerosis (FSGS)Drug: Bleselumab;Drug: Basiliximab;Drug: Mycophenolate Mofetil (MMF);Drug: Tacrolimus Capsules;Drug: Methylprednisone;Drug: PrednisoneAstellas Pharma Global Development, Inc.Kyowa Kirin Co., Ltd.Completed18 YearsN/AAll71Phase 2United States;Canada
2NCT00956059
(ClinicalTrials.gov)
September 200910/8/2009Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental GlomerulosclerosisTherapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental GlomerulosclerosisFocal Segmental GlomerulosclerosisDrug: prednisone, FK506, MMF;Drug: prednisoneXi’an Jiaotong University College of MedicineNULLNot yet recruiting16 Years70 YearsBoth40N/AChina
3NCT00135811
(ClinicalTrials.gov)
November 200424/8/2005Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)Focal Segmental Glomerulosclerosis Clinical TrialGlomerulosclerosis, FocalDrug: Cyclosporin;Drug: MMF and DexamethasoneNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)The Cleveland ClinicCompleted2 Years40 YearsBoth207Phase 3United States